Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion

NCT ID: NCT01994317

Last Updated: 2015-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

196 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion. The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale. Secondary outcomes include pain scores with cervical dilation and 15 minutes post-procedure, subjective pain ratings, incidents of side effects and adverse events, the frequency of additional doses of medication, recovery room time, and physician assessment of and satisfaction with pain control. Investigators hypothesize that this algorithm will result in improved pain control, decreased frequency of additional medication doses, improved patient and physician satisfaction, without differences in side effects, adverse events or recovery room time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy, Unplanned

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard sedation dose

IV sedation dose calculated using current standard of care

Group Type ACTIVE_COMPARATOR

Standard care

Intervention Type OTHER

IV sedation dosing calculated by standard care.

Algorithm

IV sedation dose calculated by study algorithm

Group Type EXPERIMENTAL

Algorithm

Intervention Type OTHER

IV sedation dosing calculated by algorithm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Algorithm

IV sedation dosing calculated by algorithm

Intervention Type OTHER

Standard care

IV sedation dosing calculated by standard care.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women age 18 or older seeking surgical abortion at Planned Parenthood League of Massachusetts (PPLM)
* Gestational age less than or equal to 13+6, confirmed by ultrasound
* Eligible for surgical abortion according to PPLM protocols
* Eligible for IV sedation per PPLM protocol, and desiring IV sedation for pain management

Exclusion Criteria

* Choice of local anesthesia for pain control
* Hypersensitivity to midazolam or fentanyl
* Ineligible for IV sedation per PPLM protocol
* Need for cervical ripening with either misoprostol or mechanical priming agent (laminaria/Dilapan)
* Unable or unwilling to complete required study procedures
* Previous participation in the study
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Society of Family Planning

OTHER

Sponsor Role collaborator

Planned Parenthood League of Massachusetts

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Principal Investigator, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

PPLM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Planned Parenthood

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SFPRF7-6

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Misoprostol in Missed Abortion
NCT06818903 NOT_YET_RECRUITING
Methadone and Medication Abortion
NCT04941443 TERMINATED PHASE4